Administrative code data (ACD), such as International Classifications of Diseases, Ninth Revision, Clinical Modification codes, are widely used in surveillance and public reporting programs that seek to identify healthcareassociated infections (HAIs); however, little is known about their accuracy. This systematic review summarizes evidence for the accuracy of ACD for the detection of selected HAIs, including catheter-associated urinary tract infection, Clostridium difficile infection (CDI), central line-associated bloodstream infection, ventilatorassociated pneumonia/events, postprocedure pneumonia, methicillin-resistant Staphylococcus aureus, and surgical site infections (SSIs). We conducted meta-analysis for SSIs and CDIs, where acceptable numbers of primary studies were available. For these 2 conditions, ACD have moderate sensitivity and high specificity, but evidence for detection of other HAIs is limited. With current low prevalence of HAIs, the positive predictive value of ACD algorithms would be low. ACD may be inaccurate for detection of many HAIs and should be used cautiously for surveillance and reporting purposes.
Currently the gold standard for the surveillance of HAIs is manual chart review by trained infection preventionists. This allows surveillance programs to implement standard criteria using a wide range of clinical information, although it leaves some room for subjectivity. However, manual data abstraction is labor intensive and associated with high cost and resource burdens [2] . Concurrently, legislative mandates and public pressure for HAI surveillance are increasing [3] . As expectations for surveillance and public reporting of HAIs increase, there is a growing need for automated or algorithmic processes for the detection of HAIs.
ACD have several attractive characteristics that could make them useful for HAI detection [4] . These codes are currently collected at all healthcare institutions in the United States by trained coders for billing and insurance claim purposes and stored in electronic form, and they link easily to other care measures. Nearly all billing procedures follow Uniform Hospital Discharge Data Set standards, which require usage of ICD-9-CM guidelines, using a standardized format. Because these data are already abstracted and readily available, there is no need for additional manual data collection. The current ICD-9-CM administrative coding system in the United States was introduced in 1979, and large-scale retrospective data are publicly available [5, 6] . Together these characteristics make ACD-based algorithms an attractive strategy for expanded HAI surveillance. The major natural limitations of ACD are that they were developed for the entirely different purpose of billing, and their coding criteria may differ from public health surveillance definitions. Also, coding for billing generally focuses on physician documentation and provided care rather than clinical information of the patient's status.
To our knowledge, there has been no systematic review to assess the accuracy of ACD for the detection of HAIs. If ACD provide inaccurate information regarding HAIs as used in hospital performance measures or financial incentive programs, it is possible that high-performance hospitals could be erroneously punished. Additionally, if ACD are used to track trends in specific HAIs by researchers or policy makers, inaccuracies could lead to the improper targeting of prevention resources.
The purpose of this systematic review is to assess the accuracy of ACD for detecting selected HAIs by determining the sensitivity and specificity of ACD compared with traditional surveillance methods. Summarized data will inform decision making regarding the utility and accuracy of specific administrative codes and code-based algorithms for HAI surveillance, research, and public reporting.
METHODS
We reviewed the performance (sensitivity, specificity, and positive and negative predictive values) of ACD to detect selected HAIs compared with current gold standards for measuring these HAIs. We evaluated studies conducted worldwide in both adult and pediatric populations in all study settings and all study designs. We followed the Meta-analysis of Observational Studies in Epidemiology (MOOSE) guideline in reporting this synthesis [7] .
Selected HAIs
Currently NHSN tracks multiple HAIs, including catheterassociated urinary tract infection (CAUTI), central line-associated bloodstream infection (CLABSI), and ventilator-associated events (VAEs) under the device-associated module and surgical site infections (SSIs) under the procedure-associated module. Additionally, Clostridium difficile infection (CDI), methicillinresistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci, and multidrug-resistant Gram-negative organisms are tracked by laboratory-based surveillance [8] . Postprocedure pneumonia (PPP) was also a target condition of surveillance until 2012. Recognizing the recent transition of criteria in National Healthcare Safety Network (NHSN) surveillance, we also included ventilator-associated pneumonia (VAP) in addition to VAE. Among those conditions, we excluded vancomycin-resistant enterococci and multidrug resistant Gramnegative organisms because of the lack of specific diagnostic codes, and we included the rest in this systematic review.
Data Sources and Searches
One investigator (M. G.) searched PubMed, EMBASE, Web of Science, and the Cumulative Index to Nursing & Allied Health Literature from 1 January 1979 to 31 December 2012 with assistance of a qualified research librarian. The last search was conducted on 15 March 2013. A full description of the search strategy is available in the Supplementary Data.
Study Selection
Inclusion criteria were as follows:
1. Reporting all true positives, true negatives, false positives, and false negatives to allow calculation of the performance criteria, including sensitivity, specificity, and predictive values of ACD to detect selected HAIs.
2. Using either ICD-9-CM or ICD-10 administrative coding systems.
3. Using current gold standard methods (microbiologic data for CDI and MRSA and standardized manual chart review by trained personals for all other HAIs).
4. Providing the list of code(s) for the detection of HAIs.
5. Not including duplicated data with another study. 6. Published between 1 January 1979 (the year when ICD-9-CM was introduced to the United States) and 31 December 2012.
After conducting the initial search and deletion of duplicates, we did a preliminary screening of 1548 articles based on titles and abstracts. Of these, 185 were considered for full-text review, and 19 were included in the systematic literature review. Of those included studies, 9 reported results for SSI, 7 reported results for CDI, 2 reported results for CAUTI, 2 reported results for VAP/VAE, 1 reported results for CLABSI, 2 reported results for MRSA, and 1 reported results for PPP. Figure 1 shows the flow chart of the search.
Data Extraction and Quality Assessment
Two reviewers abstracted data independently using a structured form and critiqued the quality of the studies. Discrepancies were resolved through a consensus process. We consulted authors when there was missing data or to determine if the study might include duplicative data from another study. We assessed the methodological and reporting quality of studies by using the Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool [9] . The QUADAS-2 checklist assessed potential bias in studies with respect to patient selection, index test, reference test, flow, and timing.
Data Synthesis and Analysis
We meta-analyzed groups of studies that examined the accuracy of administrative data for the same HAI type. We decided a priori to only pool the results when there were >3 studies on the same HAI of interest. We performed statistical analyses by R version 3.0 with mada package version 0.5.4 [10] . For our meta-analysis of estimates of diagnostic accuracy, we used a bivariable model, which enables simultaneous pooling of sensitivity and specificity with mixed-effect linear modeling while allowing for the trade-off between them [11] . We calculated the pooled sensitivity, specificity, positive likelihood ratio (LR), negative LR, and diagnostic odds ratio (DOR). Positive LR >10 and negative LR <0.1 provide strong diagnostic evidence, and LRs of 0.1-0.5 were interpreted as moderate diagnostic evidences [12] . Positive predictive values (PPVs) and negative predictive values (NPVs) were estimated from current reported prevalence of HAIs in the United States and pooled sensitivities/specificities because no method of meta-analysis for diagnostic accuracies has the capability to directly calculate pooled estimates of PPV and NPV. Continuity corrections of 0.5 were used for zero observations.
Considering possible international variation of coding practice, we also reported subgroup analysis of studies from the United States, in addition to global assessment and clinically relevant subgroups. Table 1 provides the individual study characteristics. Three studies reported diagnostic accuracy for >1 type of HAI [24] [25] [26] . Fifteen of 19 studies were conducted in the United States [14-17, 19, 21-25, 27-31] . Sample sizes ranged 193-930 692 persons. All studies were published after the year 2000. Supplementary Table 2 reports the list of included codes. Table 2 summarizes study quality assessments by the QUADAS-2 checklist. Seventeen studies were cross-sectional or cohort, whereas the other 2 were case-control studies. Two studies reported a financial relationship with or received funding from industry, 6 omitted disclosure of conflicts of interest, and 11 explicitly declared no relevant conflict of interest.
Results

Characteristics of Studies
Study Quality
Results Pooled by Each HAI and Subgroup Table 1 includes estimates of sensitivity, specificity, PPV, and NPV from included studies [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] . Supplementary Table 1 provides the raw data.
Clostridium difficile Infection
All C. difficile infection studies included only 1 diagnostic code (ICD-9-CM: 008.45; ICD-10: A04.7) for ACD. Table 3 lists pooled estimates for all studies and the subgroup of studies completed in the United States. When the 7 estimates were combined, the pooled sensitivity was 76.0% (95% CI, 56.2%-88.7%), and the pooled specificity was 99.9% (95% CI, 99.6%-100%). Positive LR, negative LR, and DOR were 682.0 (95% CI, 222.0-1590.0), 0.25 (95% CI, 0.11-0.44), and 2830.0 (95% CI, 1070.0-6140.0), respectively, meaning that the ACD for C. difficile infection provide moderate to strong diagnostic evidence.
When these parameters were applied to currently reported incidence of CDI (8.75 per 1000 discharges) in US acute care hospitals [32] , estimated PPV was 87.0% (95% CI, 66.2%-100%), and estimated NPV was 99.7% (95% CI, 99.6%-99.9%). Two studies with low sensitivities were completed outside the United States (France [18] and Singapore [13] ), and pooled sensitivity increased to 85.8% (95% CI, 73.2%-93.0%) with minimal decrease on pooled specificity (99.7%; 95% CI, 99.5%-99.9%) and DOR (2690.0; 95% CI, 1070.0-6140.0) in a subgroup analysis limited to US studies. When these parameters were applied to same reported incidence, estimated PPV was 71.6% (95% CI, 62.1%-86.6%) with NPV of 99.9% (95% CI, 99.8%-99.9%).
Surgical Site Infections
The number of diagnostic codes varied among studies, ranging from 1 to 103, and all studies exclusively used ICD-9-CM as a coding system. Table 3 reports pooled accuracy of ACD for SSI overall and for subgroups. Among all 9 data points, the pooled Approximately 85% of the total sample was derived from orthopedic procedures. Subgroup analysis of orthopedic procedures demonstrated higher sensitivity (88.3%; 95% CI, 65.2%-96.8%) and DOR (370.0; 95% CI, 219.0-585.0), with no trade-off decrease in pooled specificity (97.9%; 95% CI, 91.2%-99.5%). Subgroup analysis of nonorthopedic procedures showed lower pooled sensitivity (76.7%; 95% CI, 46.3%-92.6%) and DOR (111.0; 95% CI, 14.0-415.0), with a slight decrease in pooled specificity (95.9%; 95% CI, 91.0%-98.1%). When these parameters were applied to reported SSI incidence of knee/hip arthroplasties (1.05 per 100 procedures [8] ), estimated PPV and NPV were 30.9% (95% CI, 10.5%-58.1%) and 99.9% (95% CI, 89.5%-99.6%), respectively.
Ventilator-Associated Pneumonia
Only 2 studies reported complete diagnostic parameters for VAP, and we were unable to perform meta-analysis because of paucity of primary studies [25, 26] . Both studies reported low to moderate sensitivity (42%-72%) and moderate to high specificity (82%-92%). The specific ICD-9-CM code (997.31) for VAP was introduced in October 2008 [33] , and no study included this new diagnostic code. Also, new NHSN criteria of VAE were not used by any of reviewed studies.
Catheter-Associated Urinary Tract Infection
Only 2 studies reported complete diagnostic parameters for CAUTI [24, 29] . Both studies reported low sensitivity (50%-52%) and high specificity (94%-99%). Neither of the studies used the same administrative code criteria as the nonpayment policy of the Center for Medicare and Medicaid Services [1] .
Central Line-Associated Bloodstream Infection
Only 1 study reported complete diagnostic parameters for CLABSI [25] . This study reported low sensitivity (48%; 95% CI, 41%-68%) and low specificity (66%; 95% CI, 64%-68%).
Postprocedure Pneumonia
One study reported complete diagnostic parameters for PPP, with only 1 surveillance-confirmed case of PPP among 991 subjects [24] . The specific ICD-9-CM code for PPP (997.32: postprocedure aspiration pneumonia) was introduced in October 2011, and no study included this new diagnostic code [33] .
Methicillin-Resistant S. aureus
NHSN is currently performing surveillance of MRSA bacteremia, but there was no study evaluated for the accuracy of ACD specifically for this condition. When the reference condition was expanded to any MRSA infection, only 2 studies reported complete diagnostic parameters for ICD-9-CM codes [30, 31] . One study evaluated the accuracy of V09 codes (infection with drug-resistant organisms) [31] , and the other study evaluated the combination of V09.0 code (infection with microorganisms resistant to penicillins) and S. aureus infection codes [30] . MRSA infection-specific codes were introduced in October 2008, but there was no study that evaluated these relatively new MRSA-specific codes [33] . These studies reported low sensitivities (24.0%-58.8%), but the reported specificity (99.3%-99.9%) and NPVs (99.1%-99.2%) were very high. PPVs of these 2 studies showed conflicting results (30.8% and 93.3%), most likely representing the difference of included codes for surveillance between these 2 studies.
DISCUSSION
This systematic review found that ACD detects CDI and SSI with moderate sensitivity and high specificity compared with traditional surveillance. Among SSIs, sensitivity was higher for orthopedic procedures with less variability. Evidence was limited regarding the accuracy of detection of other HAIs.
The moderate sensitivity for CDI and SSI means that ACD may miss important cases of HAI. In addition, the relatively low prevalence of HAIs will limit the positive predictive value of ACD, despite their moderate sensitivity and high specificity. Thus, as increasing attention is paid to HAI prevention, lower infection incidence in the future with the accompanying lower PPVs will further compromise the utility of ACD. These findings suggest that ACD may be a useful as a part of algorithmic automated HAI surveillance but should not be the sole primary casefinding method in hospital performance measurement or epidemiologic research. If validated, ACD could potentially streamline the confirmatory process in automated surveillance if applied to cases identified by other means but must be combined with other methods if used as a part of primary case-finding process. There is a great potential for automated algorithmic surveillance systems to save burden of resources and eliminate variability between surveyors [34] , but ACD need to be carefully implemented only as a supplemental component and only after validation.
We were unable to provide reliable summary diagnostic performances for CAUTI, CLABSI, VAE/VAP, PPP, and MRSA because of the limited number of studies for these conditions. We suspect this lack of evidence is, in part, because of the lack of specific codes for these conditions, which has only recently begun to change. For example, the specific ICD-9-CM code for CLABSI was introduced in October 2011. The same limitations are also applicable to other recently introduced codes for VAE/ VAP (October 2008), MRSA infections (October 2008), and PPP (October 2012) [33] . Also, the ACD for CAUTI need both the 996.64 (infection and inflammatory reaction due to indwelling urinary catheter) code and 1 of many urinary tract infections codes, and multiple studies pointed out significant underuse of the 996.64 code [29, 35] .
The Centers for Disease Control and Prevention also periodically revises surveillance definitions for HAIs to incorporate algorithmic approaches and eliminate ambiguous components. Similarly, new microbiologic technologies can potentially affect accuracy of ACD by influencing the prevalence and interpretation of results. This is particularly true in CDI, for which new molecular diagnostic technologies are emerging. Verification studies for the accuracy of ACD need to be repeated when newly introduced HAI surveillance definitions or microbiologic technologies are introduced as reference standards.
Additionally, caution needs to be given for the interpretation of studies from nations other than the United States because of possible international variation of coding practice. For example, billing codes are assigned by treating physicians in France, in contrast with trained coders in the United States [18] .
Our systematic review has several limitations. First, the relative paucity of primary studies may limit the reliability of some results. However, we analyzed acceptable numbers of primary studies with large total sample sizes for CDI and SSI, which suggest our results give reasonably accurate performance estimates for those conditions. Also, the paucity of data for most HAIs is in itself an important finding of this review because it emphasizes the vital need for further studies in this area. Second, we performed wide-ranging literature searches on multiple databases, but we could have missed studies in this rapidly emerging field. Third, we could not include studies that only provided information for PPVs or sensitivities. Both univariable and bivariable approaches for meta-analysis of studies of diagnostic accuracy require primary studies to provide the data necessary to complete 2 × 2 tables to be eligible. Many studies without information on the number of true negatives had to be excluded [36] [37] [38] [39] [40] . Finally, all of the included studies were published after the year 2000. Lack of evidence from the previous century may limit the generalizability of our results to retrospective analysis of older data.
To our knowledge, this is the first systematic review and meta-analysis to synthesize the global evidence on accuracy of ACD for HAI detection and provide a foundation for the interpretation of ACD in relation to traditional surveillance. We emphasize that ACD should be used with extreme caution and only after validation when interested parties are using it for hospital quality measurement, financial incentive programs, and research. The unintended consequences of relying on indirect proxy measures such as ACD can be significant as the targets of HAI surveillance continue to expand.
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